UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
(Check one):
[X] Form 10-K [ ] Form 20-F [ ] Form 11-K
[ ] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR
For Period Ended: March 31, 2026
[X] Transition Report on Form 10-K
[ ] Transition Report on Form 20-F
[ ] Transition Report on Form 11-K
[ ] Transition Report on Form 10-Q
[ ] Transition Report on Form N-SAR
For the Transition Period Ended:
Nothing in this form shall be construed to
imply that the Commission has verified any information contained herein.
If the notification relates to a portion of
the filing checked above, identify the Item(s) to which the notification relates:
PART
I — REGISTRANT
INFORMATION
Avai Bio, Inc.
(formerly Avant Technologies, Inc., Trend Innovations
Holding Inc. and FREECOOK)
Full Name of Registrant
5348 Vegas Drive
Address of Principal Executive Office (Street and Number)
Las Vegas, NV 89108
State and Zip Code
PART
II — RULES
12b-25(b) AND (c)
If the subject report could not be filed without
unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box
if appropriate)
| |
|
| |
|
| [X] |
(a) The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense |
| |
(b) The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11- K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q, or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and |
| |
(c) The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable. |
PART
III — NARRATIVE
State below in reasonable detail why Forms 10-K
or 10-KSB, 20-F, 11-K, 10-Q or 10-QSB, 10-D, N-SAR, N-CSR, or the transition report or portion thereof, could not be filed within the
prescribed time period.
The Annual Report on Form 10-K of Avai Bio,
Inc. for the fiscal year ended March 31, 2026, could not be filed on schedule due to the additional time required to complete the preparation
and compilation of the Registrant's financial statements and related disclosures. The Registrant expects to file the annual report within
the extension period of fifteen calendar days provided under Rule 12b-25 of the Securities Exchange Act of 1934, as amended.
PART
IV — OTHER
INFORMATION
(1) Name and telephone number of person to contact in regard to this
notification
Vitalis Racius
(Name)
+1
(Area Code)
T: 540 495 0016
(Telephone Number)
(2) Have all other periodic reports required
under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding
12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s).
[X] Yes [ ] No
(3) Is it anticipated that any significant change
in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included
in the subject report or portion thereof?
[ ] Yes [X] No
If so, attach an explanation of the anticipated
change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be
made.
|
AVAI BIO, INC.
( Formerly AVANT TECHNOLOGIES, INC. ,
TREND INNOVATIONS HOLDING INC.
and FREECOOK ) |
|
(Name of Registrant as Specified in Charter) |
| |
|
has caused this notification to be signed on its behalf
by the undersigned hereunto duly authorized.
Date: June 30, 2026 By: /s/ Vitalis Racius
|
| |
| |
|
|
|
|
|
